Developer docs
API playgroundTry for free, no card

Search company profiles

Mandolin

Full company profile

uuid0000tae

Namestring
Mandolin
Legal namestring
Coral Automation Inc.
Websiteurl
mandolin.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Mandolin (legally Coral Automation Inc.) is a San Francisco-based AI healthcare automation company founded in 2024 by repeat entrepreneurs Will Yin and Rohit Rustagi. The company provides an AI agentic operating system that automates the end-to-end administrative workflows associated with specialty drug administration for healthcare providers, including infusion centers, specialty pharmacies, and health systems. Its platform deploys AI agents that reason, click, call, and follow up to navigate electronic health records, insurance payer portals, and telephony systems, executing tasks including referral intake, benefits verification, patient out-of-pocket estimation, prior authorization submission, and claims status tracking, without requiring customer-side APIs or integrations. The platform is designed with full action auditability and operates under HIPAA-compliant Business Associate Agreements with healthcare customers.

As of 2025, the platform is deployed across more than 700 clinic locations serving approximately 250,000 new patients annually, with documented customer outcomes including a 24x improvement in document processing speed, elimination of multi-day prescription backlogs, and replacement of 100+ FTEs at a single national AIC customer. Mandolin generates revenue through an enterprise SaaS subscription model sold via a direct, sales-led motion to healthcare organizations; pricing is quote-based and not publicly disclosed. The company raised $40 million in combined seed and Series A funding in 2025 led by Greylock Partners, with SignalFire and Maverick co-leading the seed, and was named to CB Insights' Digital Health 50 list in the same year.

Short descriptiontext

Mandolin (Coral Automation Inc.) is an AI healthcare automation company deploying agentic AI to perform end-to-end administrative workflows for specialty drug administration, serving infusion centers, specialty pharmacies, and health systems across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersIndianapolis, United States
HQ citystring
Indianapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty drug automation, healthcare workflow software, prior authorization automation, revenue cycle management, AI agentic platforms
Industry1 code
PRIMARYHLACAFAN
RPM Reimbursement, Billing & Program Operations Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Software Publishers5132
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Workflow Automation Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare SaaS Platform
TypeSubscription Recurring
Description

SaaS subscription model for healthcare organizations (infusion centers, specialty pharmacies, health systems) to automate specialty drug administration workflows. Revenue derived from automating administrative tasks including intake, benefits verification, prior authorizations, and revenue cycle management.

mandolin.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Mandolin is an AI-powered automation platform that deploys autonomous agents to execute the end-to-end administrative lifecycle of specialty drug administration, including intake, benefits verification, prior authorizations, patient out-of-pocket estimation, and revenue cycle management. The platform operates without customer APIs or integrations, with AI agents navigating EHRs, payer portals, faxes, and phone systems directly. It is sold as a SaaS subscription to healthcare providers such as infusion centers, specialty pharmacies, and health systems in the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 24x improvement in document processing speed (from 20 min/document to 3 min/document)
+4 more records
Product overview1 text field

Mandolin offers a single unified AI automation platform for specialty drug administration, built on its proprietary Agentic Operating System. The platform consists of interconnected workflow modules — Intake & Onboarding, Benefits Verification, Patient Out-of-Pocket Estimation, Medical Policy Review & Prior Authorization, and Claims Statusing & Appeal Automation — that together automate the complete administrative lifecycle of specialty drug access. The platform operates without customer APIs or integrations; AI agents autonomously navigate EHRs, payer portals, and telephony systems to execute all workflow steps. The architecture emphasizes end-to-end automation with transparency, auditable actions, and compliance with healthcare regulations.

Product and service2 records
1Mandolin AI Automation Platform
CategoryHealthcare Workflow Automation Platform
Description

AI-powered automation platform that uses autonomous agents to execute end-to-end administrative workflows for specialty drug administration, replacing fragmented back-office tasks at infusion centers, specialty pharmacies, and health systems. Sold as a SaaS subscription on quote-based enterprise pricing.

2Agentic Operating System
CategoryAI Platform Technology
Description

Core technology platform underpinning Mandolin's automation, using AI agents with vision, language, and multimodal reasoning and universal context preservation to handle specialty drug administrative workflows end-to-end. Built with strict safety checks, human oversight, and transparent auditable actions.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Major Infusion Providers
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnerships with major infusion providers for deployment of AI agents across their clinic networks serving approximately 250,000 new patients annually.

businesswire.com
2Major Specialty Pharmacies
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnerships with specialty pharmacies for integration into drug dispensing and administration workflows.

businesswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health system partnerships for enterprise-scale deployment of specialty drug automation across multiple facilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mandolin

Healthcare Workflow Automation Softwaremandolin.com

Mandolin (Coral Automation Inc.) is an AI healthcare automation company deploying agentic AI to perform end-to-end administrative workflows for specialty drug administration, serving infusion centers, specialty pharmacies, and health systems across the United States.

What Mandolin does

Mandolin (legally Coral Automation Inc.) is a San Francisco-based AI healthcare automation company founded in 2024 by repeat entrepreneurs Will Yin and Rohit Rustagi. The company provides an AI agentic operating system that automates the end-to-end administrative workflows associated with specialty drug administration for healthcare providers, including infusion centers, specialty pharmacies, and health systems. Its platform deploys AI agents that reason, click, call, and follow up to navigate electronic health records, insurance payer portals, and telephony systems, executing tasks including referral intake, benefits verification, patient out-of-pocket estimation, prior authorization submission, and claims status tracking, without requiring customer-side APIs or integrations. The platform is designed with full action auditability and operates under HIPAA-compliant Business Associate Agreements with healthcare customers.

As of 2025, the platform is deployed across more than 700 clinic locations serving approximately 250,000 new patients annually, with documented customer outcomes including a 24x improvement in document processing speed, elimination of multi-day prescription backlogs, and replacement of 100+ FTEs at a single national AIC customer. Mandolin generates revenue through an enterprise SaaS subscription model sold via a direct, sales-led motion to healthcare organizations; pricing is quote-based and not publicly disclosed. The company raised $40 million in combined seed and Series A funding in 2025 led by Greylock Partners, with SignalFire and Maverick co-leading the seed, and was named to CB Insights' Digital Health 50 list in the same year.

Mandolin firmographics

Firmographics
Name
Mandolin
Legal name
Coral Automation Inc.
Website
https://mandolin.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Mandolin (Coral Automation Inc.) is an AI healthcare automation company deploying agentic AI to perform end-to-end administrative workflows for specialty drug administration, serving infusion centers, specialty pharmacies, and health systems across the United States.
Ownership category
akta.pro rank

Mandolin industry classification

Industry
Product category
Healthcare Workflow Automation Software
NAICS
Software Publishers (5132), Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAFAN
RPM Reimbursement, Billing & Program Operations Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Specialty drug automation
  • Healthcare workflow software
  • Prior authorization automation
  • Revenue cycle management
  • AI agentic platforms

Where Mandolin is headquartered

Location

Headquarters

HQ city
Indianapolis
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Mandolin business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Healthcare SaaS Platform: SaaS subscription model for healthcare organizations (infusion centers, specialty pharmacies, health systems) to automate specialty drug administration workflows. Revenue derived from automating administrative tasks including intake, benefits verification, prior authorizations, and revenue cycle management.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Mandolin product offering

Product offering

Core offering

Mandolin is an AI-powered automation platform that deploys autonomous agents to execute the end-to-end administrative lifecycle of specialty drug administration, including intake, benefits verification, prior authorizations, patient out-of-pocket estimation, and revenue cycle management. The platform operates without customer APIs or integrations, with AI agents navigating EHRs, payer portals, faxes, and phone systems directly. It is sold as a SaaS subscription to healthcare providers such as infusion centers, specialty pharmacies, and health systems in the United States.

Product overview

Mandolin offers a single unified AI automation platform for specialty drug administration, built on its proprietary Agentic Operating System. The platform consists of interconnected workflow modules — Intake & Onboarding, Benefits Verification, Patient Out-of-Pocket Estimation, Medical Policy Review & Prior Authorization, and Claims Statusing & Appeal Automation — that together automate the complete administrative lifecycle of specialty drug access. The platform operates without customer APIs or integrations; AI agents autonomously navigate EHRs, payer portals, and telephony systems to execute all workflow steps. The architecture emphasizes end-to-end automation with transparency, auditable actions, and compliance with healthcare regulations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mandolin AI Automation Platform AI-powered automation platform that uses autonomous agents to execute end-to-end administrative workflows for specialty drug administration, replacing fragmented back-office tasks at infusion centers, specialty pharmacies, and health systems. Sold as a SaaS subscription on quote-based enterprise pricing.
  • Agentic Operating System Core technology platform underpinning Mandolin's automation, using AI agents with vision, language, and multimodal reasoning and universal context preservation to handle specialty drug administrative workflows end-to-end. Built with strict safety checks, human oversight, and transparent auditable actions.

Quantifiable outcome

  • 24x improvement in document processing speed (from 20 min/document to 3 min/document)
  • +4 more outcomes

Companies that use Mandolin

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Mandolin technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature7 records

Mandolin partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Major Infusion ProviderscoreStrategic or Co-development PartnerStrategic partnerships with major infusion providers for deployment of AI agents across their clinic networks serving approximately 250,000 new patients annually.
  • Major Specialty PharmaciescoreStrategic or Co-development PartnerPartnerships with specialty pharmacies for integration into drug dispensing and administration workflows.
  • Major Health SystemscoreStrategic or Co-development PartnerHealth system partnerships for enterprise-scale deployment of specialty drug automation across multiple facilities.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Mandolin competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Mandolin social profiles

Digital presence

Mandolin compliance and trust

Trust signal

Compliance1 record

Mandolin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mandolin leadership team

Management profile

Number of profiles

Profiles2 records

Mandolin funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mandolin M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mandolin

What does Mandolin do?

Mandolin is an AI-powered automation platform that deploys autonomous agents to execute the end-to-end administrative lifecycle of specialty drug administration, including intake, benefits verification, prior authorizations, patient out-of-pocket estimation, and revenue cycle management. The platform operates without customer APIs or integrations, with AI agents navigating EHRs, payer portals, faxes, and phone systems directly. It is sold as a SaaS subscription to healthcare providers such as infusion centers, specialty pharmacies, and health systems in the United States.

Is Mandolin a public or private company?

Mandolin is a private company. It is classified as venture growth investor backed and is currently operating.

When was Mandolin founded?

Mandolin was founded in 2024. It employs 11 to 50 people.

Where is Mandolin based?

Mandolin is headquartered in Indianapolis, United States, in the North America region.

How does Mandolin make money?

One revenue line is on record: healthcare SaaS Platform.

Does Mandolin have an API?

No public API is recorded for Mandolin.

What industry is Mandolin in?

Mandolin's product category is Healthcare Workflow Automation Software. Its primary akta.pro industry code is HLACAFAN, RPM Reimbursement, Billing & Program Operations Platforms. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogMandolin Raises $40M to Improve Access to Life-Saving Therapies for Diseases like Cancer and Alzheimer's Using AI AgentsMandolin, an AI automation platform for specialty drug access, raised $40 million in Series funding from Greylock Partners, SignalFire, Maverick, SV Angel, and individual investors Jerry Yang and Guillermo Rauch. Founded in 2024 by repeat entrepreneurs Will Yin and Rohit Rustagi, the company uses AI agents to automate the administrative process for specialty therapies such as those for cancer, Alzheimer's, and immune disorders, reducing time-to-treatment from weeks to days and cutting back-office costs for healthcare providers. Since launching its product in January, Mandolin has been deployed across over 700 clinic locations serving approximately 250,000 new patients annually through partnerships with major infusion providers, pharmacies, and health systems.Digital Music NewsMandolin Shuts Down After Burning Through $17 Million in 3 YearsLivestreaming concert platform Mandolin announced on April 17 that it is shutting down its product and business operations after nearly three years. The company, which raised a total of $17 million in funding, cited an inability to secure further investment amid changing market dynamics where live performances returned. This closure marks the end of efforts to replace physical touring with digital fan engagement platforms.VarietyLivestream Platform Mandolin Shuts Down After Three YearsMandolin, a live-stream concert platform, closed on Monday after three years, citing the resurgence of live touring. It launched in June 2020, won the 2021 Pollstar Award for best streaming platform, and had tested digital services like ticket add-ons and replays. The company urged fans to redirect spending to artists' official channels.TechCrunchMandolin adds custom artist pages, fan data analytics hubMandolin launched Fan Navigator and Fan Pages to help artists collect fan data and drive engagement. The platform combines data from Chartmetric, Mailchimp, Shopify, and others into a single dashboard with over 75 metrics. AI will segment fans into categories like casual to superfan.WaterandmusicMusic livestreaming's total (un)addressable marketMRC Data's 2021 U.S. Music 360 report reveals that only 5% of the U.S. general population attended or plans to attend virtual concerts or livestreamed performances, a dramatic decline from the 20-25% engagement rates recorded during the COVID-19 pandemic peak in 2020. This drop in consumer demand contrasts sharply with the roughly $1 billion in venture capital invested in music livestreaming platforms in 2021 alone, raising questions about the viability of livestreaming as a standalone business model as live concerts return. The article notes that some startups like Mandolin are pivoting toward hybrid models combining in-person and digital experiences, while Live Nation's acquisition of Veeps signals that major entertainment corporations may pursue music livestreaming startups for infrastructure rather than market opportunity.FinSMEsMandolin Closes $12M in Series A FundingMandolin, an Indianapolis-based digital fan engagement company, has closed a $12 million Series A funding round. The investment was led by 645 Ventures and Foundry Group, with participation from High Alpha and TIME Ventures, and included the appointment of Nnamdi Okike to Mandolin's board. The company plans to utilize these funds to expand its livestreaming capabilities and enhance its data and software offerings for artists and venues.EgirisimCanlı yayın konser platformu Mandolin, 12 milyon dolar yatırım aldıMandolin, canlı yayın konser platformu olarak 12 milyon dolarlık Seri A yatırım turunu tamamladı. Şirket, bu yatırımla hibrit konser deneyimi sunan Live+ platformunu geliştirmeyi ve pandemi sonrası dijital ile fiziksel etkinlikleri birleştirmeyi hedefliyor.BillboardMandolin Raises $12 Million to Fuel Post-Pandemic Livestreaming StrategyLivestreaming startup Mandolin has raised $12 million in Series A funding from 645 Ventures, Foundry Group, High Alpha and TIME Ventures, with High Alpha and Salesforce founder Marc Benioff also participating in its October 2020 seed round. CEO Mary Kay Huse plans to grow the company from 50 to about 100 employees, with roughly half in Indianapolis.TechCrunchConcert livestreaming platform Mandolin raises $12MIndianapolis-based startup Mandolin has raised a $12 million Series A funding round co-led by 645 Ventures and Foundry Group to expand its concert livestreaming platform. The company plans to use the capital to develop digital companion apps for in-person events and enhance its streaming capabilities as venues reopen. This investment follows a previous $5 million seed round and positions Mandolin to capitalize on the growing demand for hybrid live entertainment experiences.TechCrunchConcert livestreaming platform Mandolin raises $12MIndianapolis-based concert livestreaming startup Mandolin announced a $12 million Series A round, co-led by 645 Ventures and Foundry Group with participation from High Alpha and TIME Ventures (Marc Benioff), just one year after its founding and following a $5 million seed round in October 2020. The company, which saw rapid growth during the pandemic as live touring halted, plans to use the funding to expand its Live+ platform that provides digital companion experiences for in-person concerts. Questions remain about Mandolin's long-term strategy as venues reopen and the pandemic-driven livestreaming boom potentially tapers.